Abstract: This invention relates to the use of a compound in formula (I) and its salts acceptable pharmaceutically in preparation of vasodilative drugs: Wherein, R1, R2, X, Y, A and B are defined in the invention.
Type:
Grant
Filed:
November 25, 2013
Date of Patent:
August 16, 2016
Assignees:
Liaoning Emmy Biological Pharmaceutical Co., Ltd., Shenyang Emmy Pharmaceutical Research Institute Co., Ltd.
Inventors:
Yan Zhou, Lirong Zhang, Jie Zhou, Xin Zhou
Abstract: The present invention relates to the compounds of formula (I) or pharmaceutically acceptable salts thereof: wherein R1, R2, X, Y, A and B are defined in the description. Also disclosed in the present invention are the methods for preparing the compounds of formula (I) or pharmaceutically acceptable salts thereof, and pharmaceutical compositions comprising the compounds of formula (I) or pharmaceutically acceptable salts thereof.
Type:
Application
Filed:
November 25, 2013
Publication date:
January 14, 2016
Applicants:
LIAONING EMMY BIOLOGICAL PHARMACEUTICAL CO., LTD, SHENYANG EMMY PHARMACEUTICAL RESEARCH INSTITUTE CO., LTD
Inventors:
Yan Zhou, Lirong Zhang, Jie Zhou, Xin Zhou
Abstract: This invention relates to the use of a compound in formula (I) and its salts acceptable pharmaceutically in preparation of vasodilative drugs: Wherein, R1, R2, X, Y, A and B are defined in the invention.
Type:
Application
Filed:
November 25, 2013
Publication date:
October 22, 2015
Applicants:
Liaoning Emmy Biological Pharmaceutical Co., Ltd., Shenyang Emmy Pharmaceutical Research Institute Co., Ltd.
Inventors:
Yan Zhou, Lirong Zhang, Jie Zhou, Xin Zhou